For Immediate Release
May 1, 2026
Media Contact: eme@stateinnovation.org
WASHINGTON, D.C. – In response to the Fifth Circuit Court of Appeals ruling in State of Louisiana et al. v. Food and Drug Administrations (FDA) Jennifer Driver, Senior Director Reproductive Freedom & Health Equity at State Innovation Exchange (SiX), issued the following response:
“Mifepristone has been a lifeline for over 7.5 million people. The judges and politicians trying to strip away this crucial — and extremely safe — medication are using every tool in their toolbox to do so. Their strategy is to spread dangerous misinformation and use federal agencies, the courts, and statehouses to do so. The playbook is clear, and it's scary.
"More than ever, state legislators are the frontlines in defending care for their constituents. These are the leaders who have moved to protect telehealth providers, shield prescribers from out-of-state prosecution, and build state-level firewalls. But they can't do it alone. The Supreme Court must begin to right its wrongs and block this ruling, immediately.”
###
About State Innovation Exchange (SiX)
State Innovation Exchange (SiX) is a national resource and strategy center that supports state legislators in advancing transformative policy and building a more equitable democracy. SiX partners with lawmakers to promote sustainable, people-centered solutions that strengthen communities and improve lives.